表紙
市場調查報告書

動物用感染疾病診斷的全球市場 至2024年的預測:免疫診斷、分子診斷、細菌感染疾病、病毒感染、寄生蟲感染疾病

Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics (Lateral Flow Assays, ELISA), Molecular Diagnostics), Animal (Companion, Farm), Pathogen (Bacteria, Viral, Parasite), Enduser - Forecast to 2024

出版商 MarketsandMarkets 商品編碼 890227
出版日期 內容資訊 英文 239 Pages
訂單完成後即時交付
價格
Back to Top
動物用感染疾病診斷的全球市場 至2024年的預測:免疫診斷、分子診斷、細菌感染疾病、病毒感染、寄生蟲感染疾病 Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics (Lateral Flow Assays, ELISA), Molecular Diagnostics), Animal (Companion, Farm), Pathogen (Bacteria, Viral, Parasite), Enduser - Forecast to 2024
出版日期: 2019年07月12日內容資訊: 英文 239 Pages
簡介

全球動物用感染疾病診斷市場預測將從2019年的14億美元,到2024年達到22億美元,在預測期間中預計將為8.4%的年複合成長率 (CAGR) 。對動物用先進感染疾病診斷工具的需求擴大,對動物來源食品的需求增加,寵物數的增加,對寵物保險的需求擴大,先進經濟各國的獸醫數增加,及疾病管理 & 疾病預防對策的增加等,成為促進動物用感染疾病診斷市場的主要原因。可是,寵物治療成本的上升,動物醫療的認識不足及新興各國的獸醫師的不足,預計某種程度抑制市場成長。

本報告提供全球動物用感染疾病診斷市場調查,市場定義和概要,對市場成長的各種影響因素及市場機會分析,各市場區隔、各地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 動物用感染疾病診斷:市場概要
  • 地區分析:動物用感染疾病診斷市場佔有率,各終端用戶、地區
  • 技術分析:動物用感染疾病診斷市場
  • 動物類型分析:動物用感染疾病診斷市場佔有率
  • 動物用感染疾病診斷市場地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題
    • 趨勢、考察

第6章 動物用感染疾病診斷市場:各技術

  • 簡介
  • 免疫診斷
  • 分子診斷
  • 其他技術

第7章 動物用感染疾病診斷市場:各動物類型

  • 簡介
  • 寵物
  • 食品生產動物
  • 食品生產動物用感染疾病診斷市場:各感染類型
  • 細菌感染疾病
  • 病毒感染
  • 寄生蟲感染疾病
  • 其他感染疾病

第8章 動物用感染疾病診斷市場:各終端用戶

  • 簡介
  • 參考實驗室
  • 動物醫院、診所
  • 照護現場/家庭檢驗
  • 研究機關、大學

第9章 動物用感染疾病診斷市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭模式、其他

第11章 企業簡介

  • BIOMERIEUX S.A.
  • HESKA CORPORATION
  • IDEXX LABORATORIES, INC.
  • IDVET
  • NEOGEN CORPORATION
  • QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE)
  • RANDOX LABORATORIES, LTD.
  • THERMO FISHER SCIENTIFIC
  • VIRBAC
  • ZOETIS, INC.

第12章 附錄

目錄
Product Code: MD 7211

"The global veterinary infectious disease diagnostics market is projected to grow at a CAGR of 8.4% during the forecast period"

Veterinary infectious disease diagnostics includes immunodiagnostic, molecular diagnostic, and other veterinary diagnostic technologies. Diagnosis is conducted using kits, reagents, consumables, and analyzers that determine the nature and cause of infectious disease and the disease condition in animals.

The global veterinary infectious disease diagnostics market is projected to reach USD 2.2 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.4% from 2019 to 2024.

Growing demand for advanced veterinary infectious disease diagnostic tools, increasing demand for animal-derived food products, growth in companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, and rising disease control & disease prevention measures are some of the key factors driving the veterinary infectious disease diagnostics market. However, rising pet care costs, lack of animal healthcare awareness and shortage of veterinarians in emerging countries are expected to limit market growth to a certain extent.

"The companion animal segment accounted for the largest share of the global veterinary infectious disease diagnostics market during the forecast period"

Based on animal type, the veterinary infectious disease diagnostics market is segmented into food-producing animals and companion animals. In 2018, the companion animals segment commanded the larger share of the veterinary infectious disease diagnostics market. The large share of this segment can be attributed to the increasing pet ownership (especially in developed countries), growing penetration of pet insurance, rising number of veterinary practitioners globally, and increasing animal disease control and disease prevention measures.

"The immunodiagnostics segment accounted for the largest share of the veterinary infectious disease diagnostics market during the forecast period"

Based on technology, the veterinary infectious disease diagnostics market is segmented into immunodiagnostics, molecular diagnostics, and other technologies. The immunodiagnostics segment accounted for the largest share of the veterinary infectious disease diagnostics market in 2018. The higher preference for advanced infectious disease diagnostic products by veterinarians, animal farm owners, government institutions & organizations, pet owners, and laboratory technicians; growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the rising applications of immunodiagnostics are supporting the growth of this application segment.

"Europe accounted for the second-largest share of the global market in 2018"

The veterinary infectious disease diagnostics market is segmented into five major regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share in 2018. Factors such as increasing companion animal ownership, rise in animal disease outbreaks, a growing number of veterinary professionals, and government support to ensure good animal health are driving the market for veterinary infectious disease diagnostics in Europe.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (31%), Tier 2 (49%), and Tier 3 (20%)
  • By Designation: C-level (28%), Director-level (19%), and Others (53%)
  • By Region: North America (33%), Europe (31%), APAC (19%), and RoW (17%)

The major players operating in the veterinary infectious disease diagnostics market are: IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), QIAGEN N.V. (Indical GmbH) (Germany), Thermo Fisher Scientific, Inc. (US), Neogen Corporation (US), Virbac (France), bioMerieux SA (France), IDVet (France), Randox Laboratories, Ltd. (UK), Heska Corporation (US), Creative Diagnostics (US), URIT Medical Electronic Group Co., Ltd (China), NTBIO Diagnostics, Inc. (Canada), Bio-X Diagnostics (Belgium), Agrolabo S.p.A (Italy), Eurolyser Diagnostica (Austria), Eurofins Technologies (Hungary), MEGACOR Diagnostik GmbH (Austria), AusDiagnostics Pty, Ltd. (Australia), Demedetic Diagnostics GmbH (Germany), Chembio Diagnostic Systems, Inc. (US), DRG Diagnostics GmbH (Germany), XpressBio (US), InBios International, Inc. (US), and Genesig (Primerdesign) (UK).

Research Coverage:

This report studies the veterinary infectious disease diagnostics market based on technology, animal type, end-user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro-markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the veterinary infectious disease diagnostics market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH LIMITATIONS AND ASSUMPTIONS
    • 2.4.1 LIMITATIONS
    • 2.4.2 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS: MARKET OVERVIEW
  • 4.2 GEOGRAPHIC ANALYSIS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY END USER & REGION, 2018
  • 4.3 TECHNOLOGY ANALYSIS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2019 VS. 2024 (USD MILLION)
  • 4.4 ANIMAL TYPE ANALYSIS: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, 2019 VS. 2024
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for advanced diagnostic devices
      • 5.2.1.2 Rising demand for animal-derived food products
      • 5.2.1.3 Growth in companion animal population
      • 5.2.1.4 Rising demand for pet insurance
      • 5.2.1.5 Increasing number of veterinary practitioners in developed economies
      • 5.2.1.6 Increasing disease control and disease prevention measures
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing pet care costs
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of animal healthcare awareness in emerging markets
      • 5.2.4.2 Shortage of veterinarians in emerging markets
    • 5.2.5 TRENDS AND INSIGHTS
      • 5.2.5.1 Increasing vegan population
      • 5.2.5.2 Adoption of web monitoring and other digital aids to detect emerging animal infectious diseases

6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 IMMUNODIAGNOSTICS
    • 6.2.1 VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET SPLIT, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
    • 6.2.2 VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET SPLIT, BY END USER, 2017-2024 (USD MILLION)
    • 6.2.3 LATERAL FLOW ASSAYS
      • 6.2.3.1 Lateral flow assays offer rapid results and sensitive & accurate diagnosis
      • 6.2.3.2 Lateral flow assays market split, by end user, 2017-2024 (USD million)
    • 6.2.4 ELISA TESTS
      • 6.2.4.1 ELISA tests have gained widespread popularity in the veterinary infectious disease diagnostics market owing to their efficacy and accurate validation of results
      • 6.2.4.2 ELISA tests market split, by end user, 2017-2024 (USD million)
    • 6.2.5 OTHER IMMUNODIAGNOSTIC PRODUCTS
      • 6.2.5.1 Other immunodiagnostics products market split, by end user, 2017-2024 (USD million)
  • 6.3 MOLECULAR DIAGNOSTICS
    • 6.3.1 VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SPLIT, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
    • 6.3.2 VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SPLIT, BY END USER, 2017-2024 (USD MILLION)
    • 6.3.3 POLYMERASE CHAIN REACTION (PCR) TESTS
      • 6.3.3.1 PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals
      • 6.3.3.2 PCR-tests market split, by end user, 2017-2024 (USD million)
    • 6.3.4 MICROARRAYS
      • 6.3.4.1 Technological advancements and the increasing incidence of infectious diseases are supporting the growth of this market
      • 6.3.4.2 Microarrays market split, by end user, 2017-2024 (USD million)
    • 6.3.5 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
    • 6.3.6 OTHER MOLECULAR DIAGNOSTICS MARKET SPLIT, BY END USER, 2017-2024 (USD MILLION)
  • 6.4 OTHER TECHNOLOGIES
    • 6.4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES-SPLIT, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
    • 6.4.2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES SPLIT, BY END USER, 2017-2024 (USD MILLION)

7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE

  • 7.1 INTRODUCTION
  • 7.2 COMPANION ANIMALS
    • 7.2.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY ANIMAL TYPE
      • 7.2.1.1 Dogs
      • 7.2.1.2 Cats
      • 7.2.1.3 Horses
      • 7.2.1.4 Other companion animals
    • 7.2.2 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE
      • 7.2.2.1 Viral Infections
        • 7.2.2.1.1 Highly contagious nature of viral diseases is a major factor driving the demand for the diagnosis of viral infections in companion animals
      • 7.2.2.2 Bacterial infections
        • 7.2.2.2.1 Bacterial infections segment accounted for the largest share of the market in 2018
      • 7.2.2.3 Parasitic infections
        • 7.2.2.3.1 Rising incidence of worm infestation in companion animals to support the growth of this market
      • 7.2.2.4 Other infections
  • 7.3 FOOD-PRODUCING ANIMALS
    • 7.3.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE
      • 7.3.1.1 Cattle
      • 7.3.1.2 Swine
      • 7.3.1.3 Poultry
      • 7.3.1.4 Other food-producing animals
  • 7.4 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE
  • 7.5 BACTERIAL INFECTIONS
    • 7.5.1 BACTERIAL INFECTIONS SEGMENT HELD THE LARGEST SHARE OF THE FOOD-PRODUCING ANIMALS MARKET, BY INFECTION TYPE
  • 7.6 VIRAL INFECTIONS
    • 7.6.1 NEED FOR EARLY DISEASE DIAGNOSIS AND PREVENTION AND GROWING AWARENESS HAVE CONTRIBUTED TO MARKET GROWTH
  • 7.7 PARASITIC INFECTIONS
    • 7.7.1 WORM INFESTATIONS ARE A SIGNIFICANT PROBLEM FOR PET AND COMPANION ANIMAL OWNERS
  • 7.8 OTHER INFECTIONS

8 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 REFERENCE LABORATORIES
    • 8.2.1 REFERENCE LABORATORIES ARE GAINING IMPORTANCE DUE TO THE INCREASING PREVALENCE OF VETERINARY INFECTIOUS DISEASES AND THE NEED FOR THEIR EARLY DIAGNOSIS
  • 8.3 VETERINARY HOSPITALS & CLINICS
    • 8.3.1 HOSPITALS & CLINICS ARE THE FIRST POINTS OF CONTACT FOR ANIMAL OWNERS
  • 8.4 POINT-OF-CARE/IN-HOUSE TESTING
    • 8.4.1 POINT-OF-CARE/IN-HOUSE TESTING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 8.5 RESEARCH INSTITUTES & UNIVERSITIES
    • 8.5.1 RESEARCH INSTITUTES & UNIVERSITIES PERFORM A LARGE NUMBER OF TESTS FOR THE IDENTIFICATION OF DISEASES IN ANIMALS

9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American veterinary infectious disease diagnostics market
    • 9.2.2 CANADA
      • 9.2.2.1 Shortage of veterinarians is a growing concern in Canada
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the largest exporter of pork in the world; this situation has boosted the need for regular diagnostic and preventive measures against infectious diseases
    • 9.3.2 UK
      • 9.3.2.1 The high burden of bovine spongiform encephalopathy to drive the adoption of veterinary infectious disease diagnostic products
    • 9.3.3 FRANCE
      • 9.3.3.1 Favorable government policies for animal healthcare to support market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Growing demand for poultry and pork meat and rising awareness about pet healthcare to support market growth
    • 9.3.5 SPAIN
      • 9.3.5.1 The growing number of veterinary facilities to drive the growth of this market in Spain
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
      • 9.4.1.1 An African swine fever epidemic adversely affected the livestock market in China
    • 9.4.2 JAPAN
      • 9.4.2.1 Increasing expenditure on pet healthcare is a key driver of the veterinary infectious disease diagnostics market in Japan
    • 9.4.3 INDIA
      • 9.4.3.1 Dearth of veterinarians is one of the restraining factors of this market in India
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 BRAZIL
      • 9.5.1.1 Brazil is the world's largest exporter of animal-derived food products
    • 9.5.2 MEXICO
      • 9.5.2.1 Willingness of pet owners to spend on pet health is driving market growth in Mexico
    • 9.5.3 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 MIDDLE EAST AND AFRICA IS AN EMERGING MARKET FOR ANIMAL HEALTHCARE

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 KEY PRODUCT LAUNCHES
    • 10.3.2 KEY EXPANSIONS
    • 10.3.3 KEY ACQUISITIONS
    • 10.3.4 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
  • 10.4 VENDOR DIVE OVERVIEW
  • 10.5 VENDOR INCLUSION CRITERIA
  • 10.6 VENDOR DIVE
    • 10.6.1 VISIONARY LEADERS
    • 10.6.2 INNOVATORS
    • 10.6.3 DYNAMIC DIFFERENTIATORS
    • 10.6.4 EMERGING PLAYERS

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1 BIOMERIEUX S.A.
  • 11.2 HESKA CORPORATION
  • 11.3 IDEXX LABORATORIES, INC.
  • 11.4 IDVET
  • 11.5 NEOGEN CORPORATION
  • 11.6 QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE)
  • 11.7 RANDOX LABORATORIES, LTD.
  • 11.8 THERMO FISHER SCIENTIFIC
  • 11.9 VIRBAC
  • 11.10 ZOETIS, INC.

Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS (2000 VS. 2030) (THOUSAND METRIC TONS)
  • TABLE 2: NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012-2017) (USD MILLION)
  • TABLE 3: NUMBER OF VETERINARY PROFESSIONALS IN DEVELOPED ECONOMIES (2012 - 2017)
  • TABLE 4: NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY
  • TABLE 5: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 6: KEY VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 7: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 8: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY ENDUSER, 2017-2024 (USD MILLION)
  • TABLE 11: LATERAL FLOW ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: LATERAL FLOW ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 13: ELISA TESTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: ELISA TESTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 15: OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: OTHER IMMUNODIAGNOSTICS PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 17: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 18: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 20: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 21: PCR TESTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: PCR-TESTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 23: MICROARRAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: MICROARRAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 25: OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: OTHER MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 27: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 29: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 30: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 31: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY ANIMAL TYPE
  • TABLE 32: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS
  • TABLE 34: SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS
  • TABLE 35: SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS
  • TABLE 36: SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS
  • TABLE 37: HORSE POPULATION, BY REGION, 2014-2017 (USD MILLION)
  • TABLE 38: SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES
  • TABLE 39: SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES
  • TABLE 40: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 41: PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS
  • TABLE 42: VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS
  • TABLE 44: BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS
  • TABLE 46: PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS
  • TABLE 48: PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS
  • TABLE 49: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE
  • TABLE 51: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 52: SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE
  • TABLE 53: SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE
  • TABLE 54: SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE
  • TABLE 55: SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE
  • TABLE 56: SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY
  • TABLE 57: SOME OF THE IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY
  • TABLE 58: SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER- FOOD PRODUCING ANIMALS
  • TABLE 59: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS
  • TABLE 61: BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 62: PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS
  • TABLE 63: VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 64: PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN FOOD-PRODUCING ANIMALS
  • TABLE 65: PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 66: PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS
  • TABLE 67: PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN FOOD-PRODUCING ANIMALS
  • TABLE 68: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 69: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 70: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 71: VETERINARY EXPENDITURE (PER VISIT) FOR CATS AND DOGS IN THE US, 2013-2018
  • TABLE 72: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 73: KEY PRODUCTS OFFERED BY MARKET PLAYERS
  • TABLE 74: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 75: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 76: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 77: NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 78: NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 79: NORTH AMERICA: VETERINARY DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 80: NORTH AMERICA: VETERINARY DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 81: NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: NORTH AMERICA: COMAPNION ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: NORTH AMERICA: FOOD-PRODUCING ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 85: US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2012 VS. 2017
  • TABLE 86: OIE REPORTABLE DISEASES AND STATUS IN THE US
  • TABLE 87: US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 88: US: VETERINARY DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 89: US: VETERINARY DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 90: KEY VETERINARY INFECTIOUS DISEASES IN CANADA
  • TABLE 91: CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 92: CANADA: VETERINARY DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 93: CANADA: VETERINARY DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 94: LIVESTOCK POPULATION IN EUROPE (2018)
  • TABLE 95: IMPORTANT ANIMAL DISEASE OUTBREAKS IN EUROPE IN 2018
  • TABLE 96: EUROPE: NUMBER OF VETERINARIANS, 2012-2016
  • TABLE 97: EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 98: EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 99: EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 100: EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 101: EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: EUROPE: COMPANION ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: EUROPE: FOOD PRODUCING ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 105: GERMANY: COMPANION ANIMAL POPULATION, 2010-2018 (MILLION)
  • TABLE 106: GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2016
  • TABLE 107: GERMANY DISEASE OUTBREAKS IN 2018
  • TABLE 108: GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 109: GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 110: GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 111: UK: COMPANION ANIMAL POPULATION, 2010-2018 (MILLION)
  • TABLE 112: ANIMAL DISEASE OUTBREAKS IN THE UK (2018)
  • TABLE 113: UK: NUMBER OF VETERINARIANS, 2014 VS. 2016
  • TABLE 114: UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 115: UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 116: UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 117: FRANCE: COMPANION ANIMAL POPULATION, 2010-2018 (MILLION)
  • TABLE 118: FRANCE: ANIMAL DISEASE OUTBREAKS IN 2018
  • TABLE 119: FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2016
  • TABLE 120: FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 121: FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 122: FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 123: ITALY: COMPANION ANIMAL POPULATION, 2016-2018 (MILLION)
  • TABLE 124: ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2016
  • TABLE 125: ITALY: DISEASE OUTBREAKS IN 2018
  • TABLE 126: ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 127: ITALY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 128: ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 129: SPAIN: INFECTIONS ANIMAL DISEASE OUTBREAKS IN 2018
  • TABLE 130: SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 131: SPAIN: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 132: SPAIN: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 133: INFECTIOUS ANIMAL DISEASE OUTBREAKS IN ROE COUNTRIES, 2018
  • TABLE 134: COMPANION ANIMAL POPULATION IN ROE, 2017 (MILLION)
  • TABLE 135: ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2016
  • TABLE 136: ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 137: ROE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 138: ROE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 139: APAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 140: APAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 141: APAC: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 142: APAC: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 143: APAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 144: APAC: COMPANION ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 145: APAC: FOOD PRODUCING ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 146: APAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 147: CHINA: LIVESTOCK POPULATION (MILLION), 2010-2016
  • TABLE 148: CHINA: IMPORT AND PRODUCTION OF BEEF, VEAL, PORK, AND CHICKEN, 2018
  • TABLE 149: CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 150: CHINA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 151: CHINA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 152: JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 153: STATISTICS RELATED TO ANIMAL HEALTHCARE AND VETERINARY INFECTIOUS DISEASE DIAGNOSTICS IN JAPAN
  • TABLE 154: JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 155: JAPAN: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 156: JAPAN: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 157: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS)
  • TABLE 158: INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 159: INDIA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 160: INDIA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 161: REST OF APAC: LIVESTOCK POPULATION, BY COUNTRY, 2010-2016 (USD MILLION)
  • TABLE 162: ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 163: ROAPAC: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 164: ROAPAC: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 165: LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY (2010-2016) (MILLION)
  • TABLE 166: LATIN AMERICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 167: LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 168: LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 169: LATIN AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 170: LATIN AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 171: LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 172: LATIN AMERICA: COMPANION ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 173: LATIN AMERICA: FOOD PRODUCING ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 174: LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 175: BRAZIL PRODUCTION AND EXPORT OF BEEF & VEAL, PORK, AND CHICKEN, 2016 VS 2018
  • TABLE 176: BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 177: BRAZIL: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 178: BRAZIL: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 179: MEXICO: INCREASE IN LIVESTOCK POPULATION (2010-2016) (MILLION)
  • TABLE 180: MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 181: MEXICO: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 182: MEXICO: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 183: ROLATAM: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 184: ROLATAM: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 185: ROLATAM: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 186: MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 187: AFRICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 188: MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2016 (MILLION)
  • TABLE 189: AFRICA: FOOD-PRODUCING ANIMAL POPULATION (MILLION)
  • TABLE 190: MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 191: MEA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT 2017-2024 (USD MILLION)
  • TABLE 192: MEA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 193: MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 194: MEA: COMPANION ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 195: MEA: FOOD PRODUCING ANIMAL DISEASE DIAGNOSTICS MARKET, BY INFECTION TYPE, 2017-2024 (USD MILLION)
  • TABLE 196: MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARIES: GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: PRODUCT-BASED MARKET SIZE ESTIMATION: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 6: END USER BASED ESTIMATION: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018 (USD MILLION)
  • FIGURE 9: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY ANIMAL TYPE, 2018
  • FIGURE 10: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 12: GROWING DEMAND FOR ADVANCED DIAGNOSTIC DEVICES AND GROWTH IN THE GLOBAL COMPANION ANIMAL POPULATION ARE DRIVING MARKET GROWTH
  • FIGURE 13: REFERENCE LABORATORIES ARE EXPECTED TO HOLD THE LARGEST SHARE OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 14: IMMUNODIAGNOSTICS SEGMENT IS EXPECTED TO HOLD A DOMINANT MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 15: COMPANION ANIMALS ARE EXPECTED TO HOLD A DOMINANT MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 16: CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: PET POPULATION (MILLION) AND PET OWNERSHIP (%) IN DEVELOPED COUNTRIES
  • FIGURE 19: US PET INDUSTRY EXPENDITURE
  • FIGURE 20: US: PET OWNERSHIP INDICATORS, 2017
  • FIGURE 21: KEY DEVELOPMENTS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FROM 2016 TO 2019
  • FIGURE 22: IDEXX LABORATORIES INC. (US) HELD THE LEADING POSITION IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET IN 2018
  • FIGURE 23: VENDOR DIVE: EVALUATION OVERVIEW
  • FIGURE 24: BIOMERIEUX S.A.: COMPANY SNAPSHOT
  • FIGURE 25: HESKA CORPORATION: COMPANY SNAPSHOT 188  
  • FIGURE 26: IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 27: NEOGEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 28: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 29: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 30: VIRBAC: COMPANY SNAPSHOT
  • FIGURE 31: ZOETIS, INC.: COMPANY SNAPSHOT
Back to Top